新型环氧树脂固化剂2-烷基苯并咪唑的研究

用实验室自制的2-烷基苯并咪唑做环氧树脂固化剂,通过示差扫描量热法(DSC)、凝胶实验、FT IR等方法研究其与环氧树脂E-51的固化过程,发现取代基碳链增加,潜伏性增加,并且有很好的力学性能和吸湿性。初步探讨了2-烷基苯并咪唑的固化机理,结果发现其与烷基咪唑近似,同样遵循Heise固化机理。     

一锅法合成2-溴甲基苯并咪唑和3，4-二氢-1H-喹喔啉-2-酮

以邻苯二胺和溴代乙酸乙酯为原料一步合成了2-溴甲基苯并咪唑和3,4-二氢-1H-喹喔啉-2-酮．研究结果表明,这两种物质的生成具有伴生性．     

对甲基苯甲醛的合成

提出了以对甲基苯甲酸为原料，经2-（4-甲基苯基）苯并咪唑的还原-水解合成对甲基苯甲醛的新方法。并讨论了还原-水解反应的条件。     

Soluble N‐substituted poly(benzimidazole imide)s via C−N coupling reaction

Novel heat‐resistant N‐substituted poly(benzimidazole imide)s (PBIIs) with good solubility were synthesized via a C ? N coupling reaction. A model reaction was carried out to assist in determining the optimal reaction conditions for the polymerization and to elucidate the chemical structures of the polymers. The structures of the resulting polymers were characterized by means of Fourier transform infrared and elemental analysis; the results showed good agreement with the proposed structures. The resulting PBIIs exhibited high glass transition temperatures (T_g > 290 ^oC) and good thermostability (T_5% > 440 ^oC). The thermal behavior in air of the PBII polymers suggests that they can be considered as a new class of high performance polyimides. © 2016 Society of Chemical Industry     

N-吡唑酰基苯并咪唑衍生物的合成研究

设计合成了5个未见文献报道的N-吡唑酰基苯并咪唑类化合物,其结构经元素分析、1HNMR、IR确证.     

国产芳纶上浆剂对聚三唑复合材料力学性能的影响

目的研究国产芳纶纤维DAF-III表面上浆剂的主要成分及其对复合材料界面性能的影响。方法用丙酮溶剂抽提纤维一定时间,分析对比去除上浆剂前后的纤维和抽提溶液,并制备DAF-III增强的聚三唑树脂复合材料,测试复合材料的力学性能。结果国产DAF-III芳纶纤维的主体结构是聚酰胺苯并咪唑,表面上浆剂主要组分是脂肪族酯类低聚物。溶剂抽提去除了纤维表面大部分上浆剂,裸露的纤维本体存在制备过程中形成的沿纤维方向的大量沟壑;去除上浆剂后,复合材料的ILSS和弯曲强度分别提高了181.2%和56.20%。结论纤维表面上浆剂对纤维以及纤维增强的复合材料力学性能影响显著,纤维与树脂通过机械锚合和氢键作用改善界面粘接。     

苯并咪唑基芳醛化合物的合成及其荧光性质研究

以带有取代基的水杨醛和各种带有取代基团的邻苯二胺为原料,合成了7种具有荧光性能的苯并咪唑基芳醛化合物。改进了实验方法,收率提高了20%左右。并使用核磁对产品进行了表征,研究其荧光性能。以2-(2-羟基苯基)苯并咪唑为对照,发现在不同位置引入醛基后荧光均有减弱,其中在苯并咪唑环上连有醛基使荧光强度明显减弱。并发现各种取代基团对苯并咪唑基芳醛化合物的荧光性能均有影响,其中硝基的消光作用明显。实验结果为进一步实验提供了重要的实验依据。     

Double Repositioning: Veterinary Antiparasitic to Human Anticancer

Drug repositioning, the approach of discovering different uses for existing drugs, has gained enormous popularity in recent years in the anticancer drug discovery field due to the increasing demand for anticancer drugs. Additionally, the repurposing of veterinary antiparasitic drugs for the treatment of cancer is gaining traction, as supported by existing literature. A prominent example is the proposal to implement the use of veterinary antiparasitics such as benzimidazole carbamates and halogenated salicylanilides as novel anticancer drugs. These agents have revealed pronounced anti-tumor activities and gained special attention for “double repositioning”, as they are repurposed for different species and diseases simultaneously, acting via different mechanisms depending on their target. As anticancer agents, these compounds employ several mechanisms, including the inhibition of oncogenic signal transduction pathways of mitochondrial respiration and the inhibition of cellular stress responses. In this review, we summarize and provide valuable information about the experimental, preclinical, and clinical trials of veterinary antiparasitic drugs available for the treatment of various cancers in humans. This review suggests the possibility of new treatment options that could improve the quality of life and outcomes for cancer patients in comparison to the currently used treatments.     

CuII Pyrazolyl-Benzimidazole Dinuclear Complexes with Remarkable Antioxidant Activity

Three dinuclear coordination complexes generated from 1-n-butyl-2-((5-methyl-1H-pyrazole-3-yl)methyl)-1H-benzimidazole ( L ), have been synthesized and characterized spectroscopically and structurally by single crystal X-ray diffraction analysis. Reaction with iron(II) chloride and then copper(II) nitrate led to a co-crystal containing 78 % of [Cu(NO₃)(μ-Cl)( L’ )]₂ ( C₁ ) and 22 % of [Cu(NO₃)(μ-NO₃)( L’ )]₂ ( C₂ ), where L was oxidized to a new ligand L^’ . A mechanism is provided. Reaction with copper chloride led to the dinuclear complex [Cu(Cl)(μ-Cl)( L) ]₂ ( C₃ ). The presence of N−H⋅⋅⋅O and C−H⋅⋅⋅O intermolecular interactions in the crystal structure of C₁ and C₂ , and C−H⋅⋅⋅N and C−H⋅⋅⋅Cl hydrogen bonding in the crystal structure of C₃ led to supramolecular structures that were confirmed by Hirshfeld surface analysis. The ligands and their complexes were tested for free radical scavenging activity and ferric reducing antioxidant power. The complex C₁ / C₂ shows remarkable antioxidant activities as compared to the ligand L and reference compounds.     

苯并咪唑类没食子酸酯抗菌化合物的性质及应用

苯并咪唑类没食子酸酯(BG)是本实验室合成的、新的抗菌化合物。本文选择了其中已经XRD确定了结构的1-没食子酸乙酯-2-(对溴)苯氧甲基苯并咪唑(BG-Br)为代表进行研究。用BG-Br乳液和BG-Br二甲亚砜溶液分别处理蓝湿皮,采用抑菌圈法和振荡法测定处理皮样的抗菌效果;将BG-Br乳液和BG-Br溶液分别与皮粉作用,对处理皮粉进行DSC分析;观察BG-Br在明胶凝胶中的渗透情况。结果表明,BG-Br的最小抑菌浓度范围为8×10-5~4×10-4g/m L,处理的皮革有较好的抗菌效果;在明胶中的渗透性较好,但处理的铬皮粉的热稳定性会有所下降。总之,这种新的材料有可能在皮革工业上应用,以制备具有一定抗菌性能的皮革。